Nigel Theobald Insider Profile
4 Followers
Nigel Theobald, Chief Executive Officer, Ten Percent Owner at N4 Pharma, holds 16.98M shares in N4 Pharma (Ticker: GB:THAT). Most recently, Nigel Theobald Bought 134,686 shares of N4 Pharma on Apr 10, 2019 for an estimated value of 5.98K .
Nigel Theobald's Trading History
| THATN4 Pharma | Apr 10, 2019 | Chief Executive Officer, Ten Percent Owner | Informative Buy | 5.98K | £97.64K | |||||||||||||||||||||||||||||
GB:THAT Insider Shares: 16.98M (1673.65%)
| ||||||||||||||||||||||||||||||||||
You May Also Like
Nigel Theobald insider profile FAQ
What is the percentage of profitable transactions made by Nigel Theobald?
The percentage of profitable transactions made by Nigel Theobald is 100%.
What is the average return per transaction made by Nigel Theobald?
The average return per transaction made by Nigel Theobald is 30.60%.
What stocks does Nigel Theobald hold?
Nigel Theobald holds: GB:THAT stocks.
What was Nigel Theobald’s latest transaction?
Nigel Theobald’s latest transaction was an Informative Buy of 5.98K .
What was Nigel Theobald's most profitable transaction?
Nigel Theobald’s most profitable transaction was an Informative Buy of GB:THAT stock on November 13, 2017. The return on the trade was 51.50%.
What is Nigel Theobald's role in N4 Pharma?
Nigel Theobald's role in N4 Pharma is Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
